Cargando…
Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure
BACKGROUND: Galectin-3 is a soluble ß-galactoside–binding lectin released by activated cardiac macrophages. Galectin-3 has been proposed for diagnosis and prognosis of HF patients. OBJECTIVES: The present study aimed to investigate the relationship between galectin-3 as a biomarker and ejection frac...
Autores principales: | Atabakhshian, Roya, Kazerouni, Faranak, Raygan, Fariba, Amirrasouli, Hushang, Rahimipour, Ali, Shakeri, Nezhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Safnek
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302500/ https://www.ncbi.nlm.nih.gov/pubmed/25614856 |
Ejemplares similares
-
Comparative Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C as Early Biomarkers for Early Detection of Renal Failure in Patients with Hypertension
por: Gharishvandi, Fatemeh, et al.
Publicado: (2015) -
Heart failure and systolic function: time to leave diagnostics based on ejection fraction?
por: Smiseth, Otto A, et al.
Publicado: (2021) -
Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity
por: Zaborska, Beata, et al.
Publicado: (2020) -
Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study
por: Mahdavi, Meisam, et al.
Publicado: (2013) -
Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches
por: Ghoreishi, Elnaz, et al.
Publicado: (2022)